Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Financial, logistical reasons to blame for most missed cancer screenings
It may be more than anxiety and forgetfulness to blame for women missing their scheduled mammograms, according to new survey data.
DOJ unveils West Coast ‘Strike Force’ as new tactic used to tackle healthcare fraud
Federal authorities said the shift to regional “Strike Force” models have proven successful, with 6,200 defendants prosecuted nationwide. The DOJ said this latest unit will take a special interest in Northern California.
Atrium Health looking to scoop up smaller nonprofit health system in $2B deal
WakeMed, a three-hospital system in the North Carolina capital region of Raleigh, would become part of Advocate Health, Atrium’s parent company, if the deal goes through. Advocate is one of the largest not-for-profit health systems in the U.S.
Johnson & Johnson becomes the latest pharmaceutical company to sign on to TrumpRx
The New Jersey-based drug developer joins AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk and Pfizer in offering products directly to patients at a discounted rate. Johnson & Johnson is currently listing four medications on the platform.
Radiologists among physician specialists facing higher risk of being sued, AMA says
About 38% of rads surveyed said they had defended against at least one lawsuit, with such specialists at a higher risk than others in internal medicine.

Financial, logistical reasons to blame for most missed cancer screenings

It may be more than anxiety and forgetfulness to blame for women missing their scheduled mammograms, according to new survey data.

DOJ unveils West Coast ‘Strike Force’ as new tactic used to tackle healthcare fraud

Federal authorities said the shift to regional “Strike Force” models have proven successful, with 6,200 defendants prosecuted nationwide. The DOJ said this latest unit will take a special interest in Northern California.

Atrium Health looking to scoop up smaller nonprofit health system in $2B deal

WakeMed, a three-hospital system in the North Carolina capital region of Raleigh, would become part of Advocate Health, Atrium’s parent company, if the deal goes through. Advocate is one of the largest not-for-profit health systems in the U.S.

Johnson & Johnson becomes the latest pharmaceutical company to sign on to TrumpRx

The New Jersey-based drug developer joins AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk and Pfizer in offering products directly to patients at a discounted rate. Johnson & Johnson is currently listing four medications on the platform.

Medical malpractice gavel diagnostic error mistake stethoscope

Radiologists among physician specialists facing higher risk of being sued, AMA says

About 38% of rads surveyed said they had defended against at least one lawsuit, with such specialists at a higher risk than others in internal medicine.

mergers and acquisitions M&A partnerships

RadNet expands into its 11th state with new $30M Trinity Health joint venture

The publicly traded imaging center operator is teaming with Saint Alphonsus Health System to jointly run five facilities in Idaho.

6 pointers to make sure the hospital legal team is appropriately engaged in AI governance, oversight

Legal and compliance teams have to serve as sentinels sizing up potential legal exposure points without turning into needlers who only slow down clinical innovation.

overweight patient seeking health advice

FDA moves to restrict compounded versions of popular GLP-1 weight loss drugs

The agency said it is seeking to exclude semaglutide, tirzepatide and liraglutide from the 503B program based on a lack of clinical evidence. Unless there’s a shortage, the pharmaceuticals would be barred from being compounded by third-parties for the purpose of treating diabetes or obesity. The FDA is seeking public comment on the proposal.